Hearing: “The Role of Purdue Pharma and the Sackler Family in the Opioid Epidemic”

Committee on Oversight and Reform

Thursday, December 17, 2020 (9:00 AM)

Meeting was rescheduled to the time and date listed above.
Select one
Washington, D.C.
This hearing is fully remote via WebEx. This hearing has been rescheduled from 12/15 to 12/17.

Witnesses

Mr. Craig Landau
President and CEO, Purdue Pharma L.P.

Added 12/16/2020 at 04:43 PM
  • Witness Statement [PDF] Added 12/17/2020 at 12:49 PM

Mr. David Sackler
Former Member of the Board of Directors, Purdue Pharma L.P.

Added 12/16/2020 at 04:43 PM
  • Witness Statement [PDF] Added 12/17/2020 at 12:49 PM

Dr. Kathe A. Sackler
Former Vice President and Member of the Board of Directors, Purdue Pharma L.P.

Added 12/16/2020 at 04:43 PM
  • Witness Statement [PDF] Added 12/17/2020 at 12:49 PM

Support Documents

  • Notice [PDF] Added 12/08/2020 at 02:33 PM
  • Memo [PDF] Added 12/08/2020 at 02:33 PM
  • Rescheduled Notice [PDF] Added 12/11/2020 at 01:20 PM
  • UC - Chairwoman Maloney - Maura Healey Statement [PDF] Added 01/21/2021 at 11:30 AM
  • UC - Rep Raskin - Letter from State Attorney General offices [PDF] Added 01/21/2021 at 11:30 AM
  • Patient Testimonials [PDF] Added 01/21/2021 at 11:36 AM

Hearing Record

  • Attendance [PDF] Added 12/17/2020 at 04:31 PM
  • QFR Responses from Purdue to Chairwoman Maloney and Rep Raskin [PDF] Added 01/30/2021 at 03:09 PM
  • QFR Responses from David Sackler [PDF] Added 02/02/2021 at 01:14 PM
  • QFR Responses from Kathe Sackler [PDF] Added 03/03/2021 at 11:12 AM

First Published: December 8, 2020 at 02:27 PM
Last Updated: March 3, 2021 at 11:12 AM